Article info

Download PDFPDF
Extended report
Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation

Authors

  • Pauline A van Schouwenburg Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Charlotte L Krieckaert Department of Rheumatology, Jan van Breemen Research Institute/Reade, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Theo Rispens Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Lucien Aarden Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Gerrit Jan Wolbink Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands Department of Rheumatology, Jan van Breemen Research Institute/Reade, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Diana Wouters Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Theo Rispens, Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Plesmanlaan 125, Amsterdam 1066CX, The Netherlands; t.rispens{at}sanquin.nl
View Full Text

Citation

van Schouwenburg PA, Krieckaert CL, Rispens T, et al
Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation

Publication history

  • Received July 23, 2012
  • Revised November 5, 2012
  • Accepted December 2, 2012
  • First published January 7, 2013.
Online issue publication 
September 04, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.